Bioanalytical Systems Inc. (BASI:NASDAQ) Investor Relations Material

Overview

Bioanalytical Systems Inc. is a pharmaceutical development company that provides contract research services and analytical systems to global pharmaceutical, drug development and medical device companies. With over 40 years of experience, the company offers a wide range of services including pharmacokinetic analysis, toxicology studies, clinical trial testing, and bioanalytical assay development. Their advanced analytical tools and expertise in the field enable them to deliver high-quality solutions in a timely and cost-effective manner. As a result, Bioanalytical Systems Inc. has established itself as a trusted partner in the pharmaceutical industry, helping companies bring new drugs and medical devices to market.

Frequently Asked Questions

What is Bioanalytical Systems Inc.'s ticker?

Bioanalytical Systems Inc.'s ticker is BASI

What exchange is Bioanalytical Systems Inc. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Bioanalytical Systems Inc.'s headquarters?

They are based in Lafayette, Indiana

How many employees does Bioanalytical Systems Inc. have?

There are 201-500 employees working at Bioanalytical Systems Inc.

What is Bioanalytical Systems Inc.'s website?

It is http://www.bioanalytical.com

What type of sector is Bioanalytical Systems Inc.?

Bioanalytical Systems Inc. is in the Healthcare sector

What type of industry is Bioanalytical Systems Inc.?

Bioanalytical Systems Inc. is in the Research Services industry

Who are Bioanalytical Systems Inc.'s peers and competitors?

The following five companies are Bioanalytical Systems Inc.'s industry peers:

- Forrester Research

- Myriad Genetics

- Cleveland Biolabs, Inc.

- National Research

- Bioanalytical Systems Inc.